Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 33
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
FEMS Yeast Res ; 22(1)2022 03 24.
Artigo em Inglês | MEDLINE | ID: mdl-35262697

RESUMO

Schizosaccharomyces pombe is an established yeast model for studying the cellular mechanisms conserved in humans, such as the DNA replication checkpoint. The replication checkpoint deals with replication stress caused by numerous endogenous and exogenous factors that perturb fork movement. If undealt with, perturbed forks collapse, causing chromosomal DNA damage or cell death. Hydroxyurea (HU) is an inhibitor of ribonucleotide reductase (RNR) commonly used in checkpoint studies. It produces replication stress by depleting dNTPs, which slows the movement of ongoing forks and thus activates the replication checkpoint. However, HU also causes side effects such as oxidative stress, particularly under chronic exposure conditions, which complicates the studies. To find a drug that generates replication stress more specifically, we tested three other RNR inhibitors gemcitabine, guanazole and triapine in S. pombe under various experimental conditions. Our results show that guanazole and triapine can produce replication stress more specifically than HU under chronic, not acute drug treatment conditions. Therefore, using the two drugs in spot assay, the method commonly used for testing drug sensitivity in yeasts, should benefit the checkpoint studies in S. pombe and likely the research in other model systems.


Assuntos
Ribonucleotídeo Redutases , Proteínas de Schizosaccharomyces pombe , Schizosaccharomyces , Proteínas de Ciclo Celular/metabolismo , Quinase do Ponto de Checagem 2/metabolismo , Replicação do DNA , Desoxicitidina/análogos & derivados , Inibidores Enzimáticos/metabolismo , Guanazol , Humanos , Hidroxiureia/farmacologia , Piridinas , Ribonucleotídeo Redutases/genética , Ribonucleotídeo Redutases/metabolismo , Ribonucleotídeo Redutases/farmacologia , Schizosaccharomyces/genética , Proteínas de Schizosaccharomyces pombe/genética , Tiossemicarbazonas , Gencitabina
2.
Inorg Chem ; 53(1): 578-93, 2014 Jan 06.
Artigo em Inglês | MEDLINE | ID: mdl-24328056

RESUMO

Two novel (µ-guanazole)-bridged binuclear copper(II) complexes with 1,10-phenanthroline (phen) or 2,2'-bipyridine (bipy), [Cu2(µ-N2,N4-Hdatrz)(phen)2(H2O)(NO3)4] (1) and [Cu2(µ-N1,N2-datrz)2(µ-OH2)(bipy)2](ClO4)2 (2) (Hdatrz = 3,5-diamino-1,2,4-triazole = guanazole), have been prepared and characterized by X-ray diffraction, spectroscopy, and susceptibility measurements. Compounds 1 and 2 differ in the aromatic amine, which acts as a coligand, and in the Cu···Cu'-bridging system. Compound 1, which contains two mono-bridged copper ions, represents the first example of a discrete Cu-(NCN-trz)-Cu' complex. Compound 2, with two triply bridged copper ions, is one of the few compounds featuring a Cu-[(NN-trz)2 + (O-aquo)]-Cu' unit. Both compounds display antiferromagnetic coupling but of different magnitude: J (µ2,4-triazole) = -52 cm(-1) for 1 and J (µ1,2-triazolate) = -115 cm(-1) for 2. The DNA binding and cleavage properties of the two compounds have been investigated. Fluorescence, viscosimetry, and thermal denaturation studies reveal that both complexes have high affinity for DNA (1 > 2) and that only 1 acts as an intercalator. In the presence of a reducing agent like 3-mercaptopropionic acid, 1 produces significant oxidative DNA cleavage, whereas 2 is inactive. However, in the presence of very small quantities of micelles filled with core-shell CdSe-ZnS quantum dots (15 nM), 1 and 2 are considerably more active and become highly efficient nucleases as a result of the different possible mechanisms for promoting cooperative catalysis (metal-metal, metal-hydrogen bonding, metal-intercalation, and metal-nanoparticle). Electrophoresis DNA-cleavage inhibition experiments, X-ray photoelectron spectroscopy studies, and fluorescence ethidium bromide displacement assays reveal that in these novel nucleases the QDs act as redox-active protein-like nanoparticle structures that bind to the DNA and deliver electrons to the copper(II) centers for the generation of Cu(I) and reactive oxygen species.


Assuntos
Aminas/química , Cobre/química , DNA/efeitos dos fármacos , Guanazol/química , Compostos Organometálicos/farmacologia , Pontos Quânticos , Compostos de Cádmio/química , Cristalografia por Raios X , DNA/química , Clivagem do DNA , Modelos Moleculares , Estrutura Molecular , Compostos Organometálicos/síntese química , Compostos Organometálicos/química , Compostos de Selênio/química , Sulfetos/química , Compostos de Zinco/química
3.
Artigo em Inglês | MEDLINE | ID: mdl-22925973

RESUMO

The purpose of this manuscript is to discuss our investigations of diprotonated guanazolium chloride using vibrational spectroscopy and quantum chemical methods. The solid phase FT-IR and FT-Raman spectra were recorded in the regions 4000-400cm(-1) and 3600-50cm(-1) respectively, and the band assignments were supported by deuteration effects. Different sites of diprotonation have been theoretically examined at the B3LYP/6-31G level. The results of energy calculations show that the diprotonation process occurs with the two pyridine-like nitrogen N2 and N4 of the triazole ring. The molecular structure, harmonic vibrational wave numbers, infrared intensities and Raman activities were calculated for this form by DFT/B3LYP methods, using a 6-31G basis set. Both the optimized geometries and the theoretical and experimental spectra for diprotonated guanazolium under a stable form are compared with theoretical and experimental data of the neutral molecule reported in our previous work. This comparison reveals that the diprotonation occurs on the triazolic nucleus, and provide information about the hydrogen bonding in the crystal. The scaled vibrational wave number values of the diprotonated form are in close agreement with the experimental data. The normal vibrations were characterized in terms of potential energy distribution (PED) using the VEDA 4 program.


Assuntos
Guanazol/química , Modelos Moleculares , Teoria Quântica , Análise Espectral Raman , Triazóis/química , Vibração , Conformação Molecular , Espectroscopia de Infravermelho com Transformada de Fourier , Termodinâmica , Titulometria
4.
Artigo em Inglês | MEDLINE | ID: mdl-21112810

RESUMO

The 3,5-diamino-1,2,4-triazole (guanazole) was investigated by vibrational spectroscopy and quantum methods. The solid phase FT-IR and FT-Raman spectra were recorded in the region 4000-400 cm(-1) and 3600-50 cm(-1) respectively, and the band assignments were supported by deuteration effects. The results of energy calculations have shown that the most stable form is 1H-3,5-diamino-1,2,4-triazole under C1 symmetry. For this form, the molecular structure, harmonic vibrational wave numbers, infrared intensities and Raman activities were calculated by the ab initio/HF and DFT/B3LYP methods using 6-31G* basis set. The calculated geometrical parameters of the guanazole molecule using B3LYP methodology are in good agreement with the previously reported X-ray data, and the scaled vibrational wave number values are in good agreement with the experimental data. The normal vibrations were characterized in terms of potential energy distribution (PEDs) using VEDA 4 program.


Assuntos
Modelos Químicos , Conformação Molecular , Teoria Quântica , Análise Espectral Raman , Triazóis/química , Vibração , Guanazol/química , Espectroscopia de Infravermelho com Transformada de Fourier , Termodinâmica
5.
Antonie Van Leeuwenhoek ; 71(3): 265-70, 1997 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-9111921

RESUMO

This review examines evolution of bacterial genomes with an emphasis on RNA based life, the transition to functional DNA and small evolving genomes (possible plasmids) that led to larger, functional bacterial genomes.


Assuntos
Bactérias/genética , Bactérias/metabolismo , Evolução Biológica , Genoma Bacteriano , RNA Bacteriano/genética , RNA Bacteriano/metabolismo , Proteínas de Bactérias/metabolismo , DNA Bacteriano/genética , DNA Bacteriano/metabolismo , Guanazol/química , Estrutura Molecular , Peptídeos/metabolismo , Plasmídeos , Vírus/genética
6.
J Mol Evol ; 38: 549-57, 1994.
Artigo em Inglês | MEDLINE | ID: mdl-11539446

RESUMO

Urazole is a five-membered heterocyclic compound which is isosteric with uracil's hydrogen-bonding segment. Urazole reacts spontaneoulsy with ribose (and other aldoses) to give a mixture of four ribosides: alpha and beta pyranosides and furanosides. This reaction occurs in aqueous solution at mild temperatures. Thermodynamic and kinetic parameters for the reaction of urazole with ribose were determined. In contrast, uracil is completely unreactive with ribose under these conditions. Urazole's unusual reactivity is ascribed to the hydrazine portion of the molecule. Urazole can be synthesized from biuret and hydrazine under prebiotic conditions. The prebiotic synthesis of guanazole, which is isosteric in part to diaminopyrimidine and cytosine, is accomplished from dicyandiamide and hydrazine. Kinetic parameters for both prebiotic reactions were measured. Urazole and guanazole are transparent in the UV, which would be a favorable property in the absence of an ozone layer on the early Earth. Urazole makes hydrogen bonds with adenine in DMSO similar to those of uracil, as established by H NMR. All of these properties make urazole an attractive potential precursor to uracil and guanazole a potential precursor to cytosine in the RNA or pre-RNA world.


Assuntos
Evolução Química , Guanazol/síntese química , RNA/química , Ribose/química , Citosina/química , Evolução Molecular , Guanazol/química , Hidrazinas/química , Espectroscopia de Ressonância Magnética , Nucleosídeos/síntese química , Uracila/química
7.
J Bacteriol ; 173(16): 4932-40, 1991 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-1860812

RESUMO

Chlamydiae are obligate intracellular bacteria that are dependent on eukaryotic host cells for ribonucleoside triphosphates but not deoxyribonucleotide triphosphates. Ribonucleotide reductase is the only enzyme known to catalyze the direct conversion of a ribonucleotide to a deoxyribonucleotide. Hydroxyurea inhibits ribonucleotide reductase by inactivating the tyrosine free radical present in the small subunit of the enzyme. In this report, we show that Chlamydia trachomatis growth is inhibited by hydroxyurea in both wild-type mouse L cells and hydroxyurea-resistant mouse L cells. Hydroxyurea was used as a selective agent in culture to isolate, by a stepwise procedure, a series of C. trachomatis isolates with increasing levels of resistance to the cytotoxic effects of the drug. One of the drug-resistant C. trachomatis isolates (L2HR-10.0) was studied in more detail. L2HR-10.0 retained its drug resistance phenotype even after passage in the absence of hydroxyurea for 10 growth cycles. In addition, L2HR-10.0 was cross resistant to guanazole, another inhibitor of ribonucleotide reductase. Results obtained from hydroxyurea inhibition studies using various host cell-parasite combinations indicated that inhibition of host cell and C. trachomatis DNA synthesis by hydroxyurea can occur but need not occur simultaneously. Crude extract prepared from highly purified C. trachomatis reticulate bodies was capable of reducing CDP to dCDP. The CDP reductase activity was not inhibited by monoclonal antibodies to the large and small subunits of mammalian ribonucleotide reductase, suggesting that the activity is chlamydia specific. The CDP reductase activity was inhibited by hydroxyurea. Crude extract prepared from drug-resistant L2HR-10.0 reticulate bodies contained an elevation in ribonucleotide reductase activity. In total, our results indicate that C. trachomatis obtains the precursors for DNA synthesis as ribonucleotides with subsequent conversion to deoxyribonucleotides catalyzed by a chlamydia-specific ribonucleotide reductase.


Assuntos
Chlamydia trachomatis/efeitos dos fármacos , Hidroxiureia/farmacologia , Adenina/metabolismo , Animais , Chlamydia trachomatis/genética , Chlamydia trachomatis/isolamento & purificação , Chlamydia trachomatis/metabolismo , Cistina Difosfato/metabolismo , DNA Bacteriano/biossíntese , Resistência Microbiana a Medicamentos , Guanazol/farmacologia , Células L , Mutação , Ribonucleotídeo Redutases/antagonistas & inibidores , Ribonucleotídeo Redutases/metabolismo , Seleção Genética
8.
Mutat Res ; 231(2): 251-64, 1990 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-2117252

RESUMO

Guanazole and aphidicolin were chosen as candidates in the search for a selective, non-genotoxic inhibitor of DNA replication which could be used instead of hydroxyurea to measure DNA repair synthesis in rat hepatocyte primary cultures by liquid scintillation counting. The genotoxicity of these 3 chemicals was studied using the Salmonella/liver homogenate assay and the autoradiographic UDS test in hepatocytes. Hydroxyurea was positive in both of these assays. Guanazole and aphidicolin did not induce DNA repair in hepatocytes. Aphidicolin was not mutagenic for Salmonella typhimurium, whereas guanazole increased the revertant numbers of strain TA102 slightly. The incorporation of [3H]thymidine was measured by liquid scintillation to determine DNA repair induced by 2-acetylaminofluorene (2-AAF), aflatoxin B1, benzo[a]pyrene, cyclophosphamide, H2O2, 6-hydroxydopamine, N-methyl-N'-nitro-N-nitrosoguanidine (MNNG), methylnitrosourea (MNU), 4-nitroquinoline-N-oxide and UV irradiation in the presence of either 10 mM hydroxyurea, 15 mM guanazole or 0.015 mM aphidicolin. Aphidicolin had an inhibitory effect on DNA repair. Except for the 3 chemicals mentioned below, the sensitivity of the DNA repair measurement was the same, no matter whether hydroxyurea or guanazole was used to inhibit replicative DNA synthesis. In the presence of hydroxyurea, DNA repair synthesis was found at lower concentrations in the case of aflatoxin B1, due to differences in the solvent control values, and in the case of H2O2, possibly due to a synergistic effect between hydroxyurea and H2O2. Guanazole allowed the detection of DNA repair induced by MNNG at lower concentrations, probably because of an antagonistic effect between hydroxyurea and MNNG. Based on these results, it was concluded that guanazole, but not aphidicolin, could be used instead of hydroxyurea to measure DNA repair synthesis by liquid scintillation in rat hepatocyte primary cultures. Although guanazole does not completely fulfill the criteria for an ideal DNA replication inhibitor, it has the advantage of being less genotoxic than hydroxyurea, and also appears to have a smaller potential to falsify the results by interacting with the test compounds.


Assuntos
Reparo do DNA/efeitos dos fármacos , Diterpenos/farmacologia , Guanazol/farmacologia , Hidroxiureia/farmacologia , Mutagênicos , Triazóis/farmacologia , Animais , Afidicolina , Células Cultivadas , Dano ao DNA , Fígado/citologia , Masculino , Testes de Mutagenicidade , Ratos , Ratos Endogâmicos , Salmonella typhimurium/efeitos dos fármacos , Raios Ultravioleta
9.
Cancer Invest ; 8(6): 587-93, 1990.
Artigo em Inglês | MEDLINE | ID: mdl-2292052

RESUMO

Methotrexate-resistant R500 cells slowly lose amplified dihydrofolate reductase (dhrf) genes with biphasic kinetics when grown in the absence of methotrexate. Both phases of gene loss were markedly accelerated by subcytotoxic drug treatments. R500 cells were passed in low concentrations of cytotoxic drugs (inhibitors of ribonucleotide reductase, type I and type II topoisomerases, and polyamine synthesis). At each passage, relative dhfr gene copy number was determined by slot blot analysis. All of these drugs were able to induce rapid loss of dhfr gene dosage in the R500 cell population. The ability of these treatments to cause the rapid emergence of a cell population with substantially reduced dhfr gene dosage indicates that either the amplified genes or those cells with the highest levels of gene amplification are selectively targeted by low-level cytotoxic stress. The complex kinetics of amplified gene loss are suggestive of differential targeting of resistant cell subpopulations.


Assuntos
Amplificação de Genes/efeitos dos fármacos , Metotrexato/farmacologia , Tetra-Hidrofolato Desidrogenase/genética , Camptotecina/farmacologia , Relação Dose-Resposta a Droga , Resistência a Medicamentos , Eflornitina/farmacologia , Guanazol/farmacologia , Hidroxiureia/farmacologia , Proflavina/farmacologia
11.
J Biol Chem ; 260(15): 8694-7, 1985 Jul 25.
Artigo em Inglês | MEDLINE | ID: mdl-2991215

RESUMO

Several known inhibitors of mammalian ribonucleotide reductase were studied for their interactions with herpes simplex virus type 1 (HSV-1) ribonucleotide reductase. MAIQ (4-methyl-5-amino-1-formylisoquinoline thiosemicarbazone) produced apparent inactivation of HSV-1 ribonucleotide reductase. Only catalytically cycling, not resting, enzyme could be inactivated. Double reciprocal replots of the rates of inactivation versus the concentration of MAIQ indicated that a reversible complex with the enzyme was formed prior to inactivation. In the presence of 10 microM CDP, the maximum rate of inactivation was 20 per h (t1/2 = 3 min). The half-maximum rate was achieved at about 15 microM MAIQ. INOX (periodate-oxidized inosine) also appeared to inactivate HSV-1 ribonucleotide reductase. In contrast to MAIQ, it readily inactivated resting as well as cycling enzyme. CDP retarded the rates of inactivation by INOX. An initial reversible complex between INOX and enzyme was not detectable under the conditions used. IMPY (2,3-dihydro-1H-pyrazolo(2,3-a)imidazole) and guanazole (3,5-diamino-1,2,4-triazole) produced reversible inhibition. Although the data with both inhibitors were most consistent with the noncompetitive inhibition model (versus CDP), the data with guanazole were also marginally consistent with the uncompetitive model.


Assuntos
Guanazol/farmacologia , Inosina/análogos & derivados , Isoquinolinas/farmacologia , Pirazóis/farmacologia , Ribonucleotídeo Redutases/antagonistas & inibidores , Simplexvirus/enzimologia , Triazóis/farmacologia , Inosina/farmacologia , Cinética
14.
Adv Enzyme Regul ; 22: 231-41, 1984.
Artigo em Inglês | MEDLINE | ID: mdl-6089512

RESUMO

The data presented here show that while the non-heme iron subunit of ribonucleotide reductase is inhibited by IMPY, hydroxyurea and MAIQ, the mechanism of inhibition by hydroxyurea and IMPY is distinct from that for MAIQ. This difference in mechanisms is expressed not only in effects of iron-chelating agents on enzyme activity and of L1210 cell growth in culture, but also in differences in responses to catalase and peroxidase. Further, these data suggest that the inhibition of reductase activity by IMPY and IMPY/iron-chelator occurs through different pathways. The same conclusion can be drawn for the inhibition of reductase by hydroxyurea and hydroxyurea/iron-chelator. It is clear that additional studies will be required to understand the exact mechanism by which hydroxyurea or IMPY and the thiosemicarbazones inhibit the non-heme iron component of ribonucleotide reductase. It will also be necessary to better define the pathways of inhibition of reductase activity by IMPY and the IMPY/iron-chelator combination (or hydroxyurea and hydroxyurea/iron-chelator combination). From these studies may come information which will allow these antitumor agents to have greater utilization in the clinical management of neoplastic diseases.


Assuntos
Guanazol/farmacologia , Hidroxiureia/farmacologia , Pirazóis/farmacologia , Ribonucleosídeo Difosfato Redutase/antagonistas & inibidores , Ribonucleotídeo Redutases/antagonistas & inibidores , Triazóis/farmacologia , Anaerobiose , Animais , Catalase/farmacologia , Divisão Celular/efeitos dos fármacos , Células Cultivadas , Desferroxamina/farmacologia , Humanos , Isoenzimas/farmacologia , Isoquinolinas/farmacologia , Leucemia L1210/enzimologia , Peroxidase , Peroxidases/farmacologia , Quinolinas/farmacologia
15.
Can J Biochem Cell Biol ; 61(2-3): 120-9, 1983.
Artigo em Inglês | MEDLINE | ID: mdl-6342725

RESUMO

N-Carbamoyloxyurea is cytotoxic for cells in culture and, like hydroxyurea and guanazole, the drug is an effective inhibitor of mammalian ribonucleotide reductase and thus DNA synthesis. In addition to ribonucleotide reductase, N-carbamoyloxyurea has a second site of action which also appears to be in the pathway of DNA synthesis. A series of drug-resistant cell lines, which contain alterations in ribonucleotide reduction, have been sequentially selected in the presence of increasing concentrations of N-carbamoyloxyurea. CDP and ADP reductase activities in these drug-resistant lines have been investigated and two types of alterations have been identified: elevated levels of enzyme activity with wild-type sensitivity to drug and altered levels of reductase with reduced drug sensitivity, probably owing to structural modification of the enzyme. Furthermore, N-carbamoyloxyurea resistant lines contain another alteration as well, presumably at a second site of drug action. They are also cross-resistant to hydroxyurea and guanazole, and studies on enzyme activity levels support our previous findings with cells selected for resistance to hydroxyurea, which showed changes in CDP reductase activity are not always coordinated with changes in ADP reductase. Although several possibilities exist, these observations are most easily explained by the existence of independent enzyme substrate binding subunits which are regulated by different mechanisms. Moreover, increases in cellular resistance were accompanied by significant increases in CDP but not ADP reductase, suggesting that an ability to maintain an adequate level of CDP reductase activity is especially important to achieve resistance to DNA synthesis inhibitors like N-carbamoyloxyurea, hydroxyurea, and guanazole.


Assuntos
Hidroxiureia/análogos & derivados , Ribonucleosídeo Difosfato Redutase/metabolismo , Ribonucleotídeo Redutases/metabolismo , Animais , Linhagem Celular , Cricetinae , Resistência a Medicamentos , Feminino , Guanazol/farmacologia , Hidroxiureia/farmacologia , Cinética , Ovário
18.
J Pharm Sci ; 71(1): 89-94, 1982 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-7057389

RESUMO

A series of guanazole prodrugs, which are less water soluble than the parent compound and have relatively higher molecular weights, was recently synthesized, and their antineoplastic activities were measured in vitro. In present work, the ionization constants and partition coefficients of these compounds were measured for the first time. In contrast to guanazole, which is a weak base, guanazole prodrugs have been shown to be weak to moderate acids due to the electronic effects of the acyl group and the heterocyclic ring. Possible tautomeric and resonance structures are presented to account for the pKa values observed. Both the inductive and resonance effects of the substituent are important in determining the values of the ionization constant. The preparation of the prodrugs not only altered the lipophilicity but also drastically changed the acid-base property of the parent compound. The observed true partition coefficient values in most guanazole prodrugs studied were higher than those calculated from the pi-constants. Under highly ionized conditions, the small amount of water in the octanol layer has a significant effect in trapping a substantial amount of the ionized species in the octanol layer and gives rise to a higher log P value than expected. Under nonionized conditions, intramolecular hydrogen bonding plays an important factor in electron delocalization and reduction of hydrogen bonding with water molecules, causing the nonionized species of the guanazole prodrugs to be more lipophilic than expected.


Assuntos
Guanazol , Triazóis , Fenômenos Químicos , Físico-Química , Guanazol/análogos & derivados , Concentração de Íons de Hidrogênio , Solubilidade , Espectrofotometria Ultravioleta
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA